Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Report of The Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group.
A multicentre, double blind, placebo controlled, randomised trial of nifedipine, metoprolol, and nifedipine and metoprolol combined was conducted in a group of 338 patients with unstable angina not pretreated with a beta blocker and of nifedipine in 177 patients pretreated with a beta blocker. The main outcome event was recurrent ischaemia or myocardial infarction within 48 hours. Trial medication effects were expressed as ratios of event rates relative to placebo. In patients not pretreated with a beta blocker the event rate ratios with associated 95% confidence intervals were 1.15 (0.83, 1.6... Mehr ...
Dokumenttyp: | TEXT |
---|---|
Erscheinungsdatum: | 1986 |
Verlag/Hrsg.: |
BMJ Publishing Group Ltd
|
Schlagwörter: | Research Article |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26713284 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://heart.bmj.com/cgi/content/short/56/5/400 |